What is LOPJLB’s current signal on OABI?

LOPJLB’s latest quantitative signal on OmniAb, Inc. (OABI) is BUY in a BEAR regime. Signals are updated daily.

What market regime is OABI in?

OmniAb, Inc. (OABI) is currently classified in the BEAR HMM market regime on LOPJLB.

Where is OmniAb, Inc. based / listed?

OmniAb, Inc. is based in US, listed on NASDAQ.

OmniAb, Inc. (OABI)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$4.79+2.79%Close

BUYBEAR · day 1

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $570M
Beta: 1.05
P/E (TTM): -12.08

Short % float: 6.94%
Days to cover: 6.8
SI change: +15.1%

1W: -1.64%
1M: +21.27%

vs SPY 1W: -2.80%
vs SPY 1M: +18.27%

Industry peers

FMP comparable companies · ranked by market cap

ABSIBUYAbsci Corporation$1.7BCRISISQ 3$10.16+13.65%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby…

Employees: 89
Headquarters: US
Founded: 2021
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 119.1M
Float: 99.2%

omniab.com ↗

Key executives

Matthew W. Foehr — President, Chief Executive Officer & Director

Charles S. Berkman — Chief Legal Officer & Secretary

Kurt A. Gustafson — Executive Vice President of Finance & Chief Financial Officer

SEC filings

EDGAR · CIK 18462530 · OABI

Analyst consensus

Buy

Bullish11100.0%

Neutral00.0%

Bearish00.0%

L $4.00Avg $4.00H $4.00

Target$4.00-16.49%

Last$4.79

Key stats

Industry peers

Prediction markets

Company news